BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6114125)

  • 1. Correlation of endogenous somatostatin, gastric inhibitory polypeptide, glucagon and insulin with gastric function in the conscious calf.
    Bell FR; Webber DE; Wass JA; Rees LH; Evans J; Morgan LM; Marks V; Lewis J
    J Endocrinol; 1981 Jun; 89(3):451-6. PubMed ID: 6114125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of circulating somatostatin, insulin, gastrin and GIP, to intraduodenal infusion of nutrients in normal man.
    Lucey MR; Fairclough PD; Wass JA; Kwasowski P; Medbak S; Webb J; Rees LH
    Clin Endocrinol (Oxf); 1984 Sep; 21(3):209-17. PubMed ID: 6148162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of somatostatin on fasting and glucose-stimulated gastric inhibitory polypeptide release in man.
    Salera M; Pironi L; Giacomoni P; Venturi S; Capelli M; Miglioli M; Barbara L
    Digestion; 1982; 24(2):126-32. PubMed ID: 6127273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rate dependent stimulation of insulin and glucagon but not gastrin and somatostatin release during the intestinal phase of a meal.
    Schusdziarra V; Dangel G; Henrichs I; Klier M; Pfeiffer EF
    Horm Metab Res; 1982 Apr; 14(4):169-71. PubMed ID: 6123480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutrient sensitivity of gastric emptying of digesta in the preruminant calf.
    Sissons JW; Bell FR; Girard CL; Wass JA
    Br J Nutr; 1988 Mar; 59(2):335-43. PubMed ID: 2896016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cholecystokinin (CCK)-8, CCK-33, and gastric inhibitory polypeptide (GIP) on basal and meal-stimulated pancreatic hormone secretion in man.
    Ahrén B; Pettersson M; Uvnäs-Moberg K; Gutniak M; Efendic S
    Diabetes Res Clin Pract; 1991 Sep; 13(3):153-61. PubMed ID: 1683622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intravenous somatostatin and motilin on the blood glucose and hormonal response to oral glucose.
    Long RG; Christofides ND; Fitzpatrick ML; O'Shaughnessy DJ; Bloom SR
    Eur J Clin Invest; 1982 Aug; 12(4):331-6. PubMed ID: 6128230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of gastric inhibitory polypeptide (GIP) by intraduodenal acidification in rats and humans and abolishment of the incretin effect of acid by GIP-antiserum in rats.
    Ebert R; Illmer K; Creutzfeldt W
    Gastroenterology; 1979 Mar; 76(3):515-23. PubMed ID: 34554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of insulin, glucagon-like peptide 1, gastric inhibitory polypeptide, and appetite in response to intraduodenal carbohydrate.
    Lavin JH; Wittert GA; Andrews J; Yeap B; Wishart JM; Morris HA; Morley JE; Horowitz M; Read NW
    Am J Clin Nutr; 1998 Sep; 68(3):591-8. PubMed ID: 9734735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of glucose-dependent insulinotropic polypeptide on gastric emptying, glycaemia and insulinaemia during critical illness: a prospective, double blind, randomised, crossover study.
    Kar P; Cousins CE; Annink CE; Jones KL; Chapman MJ; Meier JJ; Nauck MA; Horowitz M; Deane AM
    Crit Care; 2015 Jan; 19(1):20. PubMed ID: 25613747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric inhibitory polypeptide does not inhibit gastric emptying in humans.
    Meier JJ; Goetze O; Anstipp J; Hagemann D; Holst JJ; Schmidt WE; Gallwitz B; Nauck MA
    Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E621-5. PubMed ID: 14678954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of somatostatin on fasting and postprandial plasma GIP, serum insulin, and blood glucose in man.
    Jorde R; Waldum HL; Burhol PG; Lygren I; Schulz TB; Florholmen J; Jenssen TG
    Scand J Gastroenterol; 1981; 16(1):113-9. PubMed ID: 6112787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of glucagon, gastric inhibitory polypeptide, pancreatic polypeptide and somatostatin on beta-adrenergically induced insulin secretion in the mouse.
    Ahrén B; Lundquist I
    Diabete Metab; 1982 Sep; 8(3):209-12. PubMed ID: 6128264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of graded intraduodenal glucose infusions on the release and physiological action of gastric inhibitory polypeptide.
    McCullough AJ; Miller LJ; Service FJ; Go VL
    J Clin Endocrinol Metab; 1983 Feb; 56(2):234-41. PubMed ID: 6337173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: evidence for more than one mechanism of action.
    Gutniak M; Grill V; Efendić S
    J Clin Endocrinol Metab; 1986 Jan; 62(1):77-83. PubMed ID: 2866196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects.
    Meier JJ; Kemmeries G; Holst JJ; Nauck MA
    Diabetes; 2005 Jul; 54(7):2212-8. PubMed ID: 15983224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the Natural Sweetener Xylitol on Gut Hormone Secretion and Gastric Emptying in Humans: A Pilot Dose-Ranging Study.
    Meyer-Gerspach AC; Drewe J; Verbeure W; Roux CWL; Dellatorre-Teixeira L; Rehfeld JF; Holst JJ; Hartmann B; Tack J; Peterli R; Beglinger C; Wölnerhanssen BK
    Nutrients; 2021 Jan; 13(1):. PubMed ID: 33429977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lowering of fasting and food stimulated serum immunoreactive gastric inhibitory polypeptide (GIP) by glucagon.
    Ebert R; Arnold R; Creutzfeldt W
    Gut; 1977 Feb; 18(2):121-7. PubMed ID: 856672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal control of gastric function in the calf: the relationship of neural and endocrine factors.
    Bell FR; Green AR; Wass JA; Webber DE
    J Physiol; 1981 Dec; 321():603-10. PubMed ID: 6121910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of calcium on the release of gastric inhibitory polypeptide (GIP) - with reference to the release of GIP in patients with hyperparathyroidism (author's transl)].
    Nakanome C; Akai H; Umezu M; Toyota T; Goto Y; Furukawa Y; Sato T; Yumita S; Bloom SR
    Nihon Naibunpi Gakkai Zasshi; 1982 Feb; 58(2):98-109. PubMed ID: 7044844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.